Filtros de búsqueda

Lista de obras de Silvia Zibellini

A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Walde

scientific article published on 05 July 2019

An insidious presentation of splenic marginal zone lymphoma.

artículo científico publicado en 2007

Biological markers and prognostic scoring systems in chronic lymphocytic leukaemia

artículo científico publicado en 2009

CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms

artículo científico publicado en 2012

Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.

artículo científico publicado en 2012

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

artículo científico publicado en 2015

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

artículo científico

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network

artículo científico publicado en 2019

Clinical significance of somatic mutation in unexplained blood cytopenia

artículo científico publicado en 2017

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

artículo científico publicado en 2013

Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.

artículo científico publicado en 2013

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.

artículo científico publicado en 2007

Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.

artículo científico publicado en 2011

HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia

artículo científico publicado en 2007

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

artículo científico publicado en 2009

IGHV unmutated status influences outcome more than IGHV1-69 gene usage per se in patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

artículo científico publicado en 2010

Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?

scientific article published on 30 January 2012

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

artículo científico publicado en 2010

JAK inhibitors and risk of B-cell lymphomas

artículo científico publicado en 2019

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2013

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2017

Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms

artículo científico publicado en 2019

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

artículo científico publicado en 2011